197 related articles for article (PubMed ID: 32101556)
1. A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
Ahmed CM; Ildefonso CJ; Johnson HM; Lewin AS
PLoS One; 2020; 15(2):e0227524. PubMed ID: 32101556
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
3. A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis.
Ahmed CM; Massengill MT; Brown EE; Ildefonso CJ; Johnson HM; Lewin AS
Exp Eye Res; 2018 Dec; 177():12-22. PubMed ID: 30048621
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein.
Chen J; Qian H; Horai R; Chan CC; Falick Y; Caspi RR
PLoS One; 2013; 8(8):e72161. PubMed ID: 24015215
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of the Interphotoreceptor Retinoid Binding ProteinInduced Models of Experimental Autoimmune Uveitis in B10.RIII versus C57BL/6 Mice.
Chen Y; Chen Z; Chong WP; Wu S; Wang W; Zhou H; Chen J
Curr Mol Med; 2018; 18(9):602-611. PubMed ID: 30636608
[TBL] [Abstract][Full Text] [Related]
7. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
[TBL] [Abstract][Full Text] [Related]
9. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
10. Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice.
Hsu SM; Yang CH; Tsai HY; Lin CJ; Fang YH; Shieh CC; Chen SH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171990
[TBL] [Abstract][Full Text] [Related]
11. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
12. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
13. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.
Meng X; Fang S; Zhang Z; Wang Y; You C; Zhang J; Yan H
Cell Mol Immunol; 2017 Aug; 14(8):702-711. PubMed ID: 26996065
[TBL] [Abstract][Full Text] [Related]
15. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
16. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
17. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
18. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells mediate the anti-inflammatory action of omega-3 long-chain polyunsaturated fatty acids in experimental autoimmune uveitis.
Uchi SH; Yanai R; Kobayashi M; Hatano M; Kobayashi Y; Yamashiro C; Nagai T; Tokuda K; Connor KM; Sonoda KH; Kimura K
PLoS One; 2019; 14(7):e0219405. PubMed ID: 31335861
[TBL] [Abstract][Full Text] [Related]
20. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
